HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Analysis of the characteristics of responders to chemotherapy of advanced hepatocellular carcinoma].

Abstract
To evaluate characteristics of the responders to chemotherapy for advanced hepatocellular carcinoma, clinicopathological findings of the responders (9 cases) and those of the non-responders (58 cases) have been compared. As for clinical characteristics, no difference was found in age and sex between the two groups. The responders were, however, restricted to the good cases in respect to performance status (PS) and hepatic reserve based on Child's classification. Concerning characteristics of tumors, no significant difference between the two groups was observed in size and number of tumors, or in the frequency of portal vein thrombosis and that of remote metastasis. There was no difference between them in chemotherapy regimen, either. It was concluded that PS and hepatic reserve might be the most important factors determining the efficacy of chemotherapy for advanced hepatocellular carcinoma.
AuthorsF Matsushita, M Unoura, T Urabe, Y Inagaki, N Tanaka, K Kobayashi, N Hattori, O Matsui
JournalNihon Gan Chiryo Gakkai shi (Nihon Gan Chiryo Gakkai Shi) Vol. 25 Issue 3 Pg. 578-85 (Mar 20 1990) ISSN: 0021-4671 [Print] Japan
PMID2161890 (Publication Type: Comparative Study, English Abstract, Journal Article)
Topics
  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Carcinoma, Hepatocellular (drug therapy)
  • Female
  • Humans
  • Liver Neoplasms (drug therapy)
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: